Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations.
Mycobacterium malmoense is an opportunistic pathogen with increasingly recognized clinical importance. It is mainly isolated in northern Europe and Great Britain, most often from patients with pulmonary infections. Conventional therapy of M. malmoense infections with antituberculosis drugs is often...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1993
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC187954/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8392308/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.6.1285 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
